DRAP decides to issue new Good Manufacturing Practice check list
It will ensure quality of manufactured drugs.
The Drug Regulatory Authority of Pakistan has decided to issue new Good Manufacturing Practice check list to ensure quality of manufactured drugs.
The decision was taken during the 254th meeting of Central Licensing Board of the Authority in Islamabad.
The board also approved New Drug Manufacturing Licenses to three new companies, additional Manufacturing Sections to six companies and Renewal of Drug Manufacturing Licenses to seven companies.
The Board issued Show Cause Notices to six companies for suspension and cancellation of Licenses on account of violation of Drug Act. The Board also approved prosecution of two accused in the Court of Law.